Skip to Content

Join the 'Breo Ellipta' group to help and get support from people like you.

Breo Ellipta News

Boxed Warning Removed From LABA/ICS Combination Asthma Medications: FDA

Posted 21 Dec 2017 by Drugs.com

New evidence regarding safety is spurring the U.S. Food and Drug Administration to remove a Boxed Warning from certain inhaled medications used to treat asthma and chronic obstructive pulmonary disease (COPD). The decision applies to a class of medications known as Long-Acting Beta Agonists (LABAs) used in combination with inhaled corticosteroid (ICS) medicines. These medicines include brand name ...

FDA Medwatch Alert: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

Posted 21 Dec 2017 by Drugs.com

ISSUE: FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related ...

Sniffing Out the Best Allergy Treatment

Posted 28 Nov 2017 by Drugs.com

TUESDAY, Nov. 28, 2017 – Seasonal allergies make life miserable for millions of Americans. So, in a bid to ease some of that discomfort, experts from two leading groups of allergists created a task force that has just issued new practice guidelines on the best ways to quell those bothersome symptoms. The consensus? For most people, nasal steroid sprays are the way to go, according to the ...

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

Posted 19 Sep 2017 by Drugs.com

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with chronic o ...

Mice May Be Key to Kids' Asthma Attacks at School

Posted 2 Dec 2016 by Drugs.com

FRIDAY, Dec. 2, 2016 – Research investigating schoolchildren's asthma attacks has pointed to a tiny foe: mice. Allergens from the rodents can infiltrate the air, the study found, and may be a major cause of asthma attacks in the school environment. It's known that many different allergy triggers – from dust mites to mold to pet dander – can fuel children's asthma symptoms. But most research ...

Fewer Inhaled Steroids May Be OK for Asthmatic Children

Posted 27 May 2016 by Drugs.com

FRIDAY, May 27, 2016 – Inhaled steroid therapy is commonly used to treat asthmatic children with persistent, daily wheezing episodes. However, a new study suggests that the powerful medicines may not be needed on a daily basis for kids whose wheezing occurs sporadically, such as when they catch a cold. "It makes sense that these children with frequent symptoms require daily treatment, whereas ...

Asthma Linked to Chronic Migraines in Some People

Posted 11 Dec 2015 by Drugs.com

FRIDAY, Dec. 11, 2015 – People with asthma may be more than twice as likely to develop chronic migraines as those without breathing troubles, a new study suggests. The research included about 4,500 Americans. At the start of the study in 2008, the study volunteers had fewer than 15 migraines a month. One year later, the researchers looked to see how many had chronic migraine – 15 or more ...

Health Tip: Live Better With Asthma

Posted 5 Oct 2015 by Drugs.com

-- By keeping your asthma under control and creating a plan for when attacks strike, asthma doesn't have to ruin your health. The U.S. National Heart Lung and Blood Institute suggests: With help from your doctor, create an asthma action plan. It should include steps for taking medication, and what to do if symptoms worsen. Learn about, and avoid, asthma triggers. Get regular medical checkups. ...

Gut Bacteria Tied to Asthma Risk in Kids

Posted 30 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 30, 2015 – The presence of four types of gut bacteria in infancy may reduce a child's risk for asthma, Canadian researchers report. Most infants get these bacteria naturally from the environment. But some babies are given antibiotics that kill these bacteria, and some are not exposed to them for various reasons, the researchers said. "We now have particular markers that seem to ...

Secondhand Smoke May Double Risk of Hospitalization for Kids With Asthma

Posted 24 Sep 2015 by Drugs.com

THURSDAY, Sept. 24, 2015 – Exposure to secondhand smoke puts children with asthma at nearly double the risk of winding up in the hospital, a new analysis reveals. For these kids, secondhand smoke can worsen symptoms and make their condition more difficult to control. So parents need to be aware of these additional risks, the researchers warned. "Previous studies have linked secondhand smoke ...

Asthma Treatments Fail Older Patients More Often: Study

Posted 12 Jun 2015 by Drugs.com

FRIDAY, June 12, 2015 – Asthma treatments, especially inhaled corticosteroids, are less likely to work for older patients, a new study suggests. Researchers looked at 1,200 patients with mild-to-moderate asthma, and found that treatment failure occurred in about 17 percent of those aged 30 and older, compared with about 10 percent of those younger than 30. Lower lung function and having asthma ...

FDA Approves Breo Ellipta (fluticasone furoate/vilanterol) for Asthma

Posted 30 Apr 2015 by Drugs.com

London, UK, and South San Francisco, CA, USA, 30 April 2015 – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the relief of acute b ...

Combo Therapy Best for COPD: Study

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – A combination drug therapy aimed at opening the airways and reducing inflammation appears to be the best treatment for older adults with chronic obstructive pulmonary disease (COPD), especially those with asthma, a new study finds. COPD patients who received a combination of long-acting beta agonists and inhaled corticosteroids were less likely to die or require ...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Asthma - Maintenance, Asthma

Breo Ellipta Patient Information at Drugs.com